China Medical Technologies Inc. announced yesterday the appointment of Dr. Guoming Qi as independent director and Dr. Yuedong Li as member for both audit committee and nomination committee, the resignation of Mr. Cole Capener from the board as well as the appointment of Dr. Zhong Chen as Chief Technology Officer (CTO), all effective November 16, 2007.
Dr. Qi is currently the Vice President of the Chinese Medical Association, the largest and long established medical association with over 400,000 members in China and holds a number of senior positions in various healthcare organizations in China.
"We are delighted to welcome Dr. Qi to our board," said Mr. Xiaodong Wu, Chairman and CEO of the Company. "Dr. Qi is a leader in Chinese medical community and we are confident that his experience and expertise will be of great benefits to the Company as we continue to expand in the Chinese healthcare market."
Dr. Chen is the Medical Director of cytogenetics program at the Associated Regional and University Pathologists (ARUP) Laboratories in Utah and a professor of Pediatrics and Pathology at the University of Utah.
Commenting on Dr. Chen's appointment as the Company's CTO, Mr. Wu said, "Dr. Chen's expertise in advanced IVD technologies will strengthen our leadership in advanced IVD businesses in China and lead the Company's expansion of advanced IVD product portfolio for both China and overseas markets."
China Medical Technologies Inc. is a leading China-based medical device company that develops, manufactures and markets advanced in- vitro diagnostic (IVD) products and high intensity focused ultrasound tumor therapy systems.